Featured Article

Crafting a Digital Strategy: The Roadmap for 2021

In many situations, technology upgradation is often construed as digital transformation. In a recently conducted survey by Altimeter, 88% of companies said that they were undergoing ‘digital transformation’ but only 25% said that they did so with the purpose beyond investing in new technology. The real definition of digital transformation is the realignment of, or new investment in technology, business models, and processes to create value for customers in a dynamic digital economy.


Sales Force Strategy in the Digital World

Does Your Company Have a Well Thought-out Strategy on How to Improve Sales Force Effectiveness in the Digital World? Most pharma companies operating in India, understand the significance of their sales force – the powerful driver of revenues. Sales force is also responsible for establishing and maintaining relationships with various…


Indian Pharma – The Emerging Role of Hybrid Sales Model

COVID-19 has accelerated the shift in how pharma was engaging with HCPs, professional organisations and even patients in India from a sales to more of a scientific, unbiased and balanced marketing communications. As one of the business leader from a prominent MNC said, “For the first time we are seeing a certain shift in HCP’s preference for scientific communication for innovators companies. MSLs and scientific operation teams will be playing a key role in the near future.”







Patient Centered Pharma – Pipe Dream or Possible?

To me, patient centricity is as fascinating a concept as it is contradictory. It is fascinating because it puts power into the hands of the patient. And it is contradictory because pharma does not like giving away power over its messages or processes. Pharma has traditionally never enjoyed interaction and has depended on ‘pushing’ messages across rather than having ‘conversations’. It probably also explains why we make do with medical reps who are not the sharpest knives in the drawer and scarcely invest in sharpening them.


Indian #Pharma Market (IPM) – August 2020 Sales

The COVID crisis has impacted IPM negatively – the growth seen in July 2020 was a mere 0.2%. This is down to -2.2% de-growth in August 2020 and shows a single digit growth of 4.1% on a MAT basis. #Cardiac has stabilized but with lower growth of 11.5% in August 2020…


MENU